Nova Patents
PL362801A1

Process for the crystallization of (r)- or (s)-lansoprazole

Abstract

This record has no abstract on file.

Term

Term ended

Projected expiry passed 30 November 2021, 4.8 years ago.

  1. Priority
  2. Filed
  3. Published
  4. Projected expiry
  5. Today

40 members in 17 offices

This recordMember, by publication datePriority claim7 more offices are in the list below

Priority claims8

Priority claims
DocumentOfficeKindDate
2000367757JapanA
2000367757JapanA
0110462JapanW
0110462JapanW
00367757–––
01JP0110462–––
JP20000367757–––
WO2001JP10462–––

Members40

Family members, oldest first
DocumentOfficeKind
CA2436825A1CanadaA1
WO0244167A1World Intellectual Property Organization (WIPO)A1
AU1850602AAustraliaA
JP2002226478AJapanA
NO20032437D0NorwayD0
KR20030060967ARepublic of KoreaA
NO20032437LNorwayL
EP1337525A1European Patent Office (EPO)A1
HK1054380AHong Kong, ChinaA
CN1478086AChinaA
US2004049045A1United States of AmericaA1
HU0400781A2HungaryA2
HUP0400781A2HungaryA2
PL362801A1This recordPolandA1
CN1254473CChinaC
US7285668B2United States of AmericaB2
TWI290922BTaiwan Province of ChinaB
NO326019B1NorwayB1
JP4160293B2JapanB2
US2008306118A1United States of AmericaA1
KR20090003348ARepublic of KoreaA
KR100887912B1Republic of KoreaB1
KR20100002278ARepublic of KoreaA
KR100939948B1Republic of KoreaB1
HU0400781A3HungaryA3
HUP0400781A3HungaryA3
CA2436825CCanadaC
EP1337525B1European Patent Office (EPO)B1
AT511508TAustriaT
ATE511508T1AustriaT1
EP2345650A1European Patent Office (EPO)A1
PT1337525EPortugalE
DK1337525T3DenmarkT3
EP1337525B8European Patent Office (EPO)B8
ES2367419T3SpainT3
HK1054380BHong Kong, ChinaB
PL399787A1PolandA1
PL214684B1PolandB1
HU229356B1HungaryB1
PL409463A1PolandA1